Richard Fagerstrom, Ph.D., an NCI mathematical statistician from the Division of Cancer Prevention, was the co-chief statistician for the National Lung Screening Trial, a nearly decade-long study that showed a 20 percent reduction in lung mortality among heavy smokers screening with low-dose CT, compared to those screened with X-ray. In this interview from June 2011, Fagerstrom discusses the trial, from concept design to primary results.
Articles Tagged ‘screening’
Sequencing techniques uncover mutations in genes that can increase cancer risk
July 18, 2012, 1:00PM
Overview of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
May 21, 2012, 11:39AM
In 1993, the National Cancer Institute launched one of the largest cancer screening trials ever planned in the United States, in an effort to answer the question of screening efficacy in four cancers: prostate, lung, colorectal, and ovarian. Ten centers across the country ultimately accrued more than 150,000 men and women for this study. Nineteen years after it began, PLCO has now released the trial’s final major outcome finding, for colorectal cancer.
NCI NewsCenter
NCI Budget Data
Visuals Online
NCI Fact Sheets
Understanding Cancer Series